High-dose once-weekly semaglutide: a new option for obesity management
#GLP1 #obesity #muscleMass #semaglutide I started in the 1970's developing exercise, nutrition and nutrition product programs for athletes to maintain lean body mass or even build lean body mass while reducing body fat mass, followed by developing various commercial products for millions of people to benefit from this approach
The mice in that study had GLP-1 effects targeted to muscle , whereas in humans the medications predominantly act on the pancreas, brain, and gut
Exercise and GLP-1 considerations GLP-1 medications reduce caloric intake, which means you have less fuel available for exercise
Do patients need liver biopsies
Currently, a number of drugs have been launched worldwide, which not only benefit type 2 diabetes patients, but also bring hope to many obesity patients